Last reviewed · How we verify
NCT06266949
Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors
trial testing SONDA in Pituitary Tumor in 30 participants. Not yet recruiting.
1 April 2026
Quick facts
| Lead sponsor | University Medical Center Groningen |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 1 August 2025 |
| Primary completion | 1 April 2026 |
| Estimated completion | 1 August 2026 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- SONDA
Conditions studied
- Pituitary Tumor — all drugs for Pituitary Tumor →
- Visual Fields Hemianopsia — all drugs for Visual Fields Hemianopsia →
Sponsor
University Medical Center Groningen
Who can join
18 and older, any sex, with Pituitary Tumor or Visual Fields Hemianopsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06266949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pituitary Tumor
Currently open trials in the same condition.
- NCT06936813 — The PROMISE Survey · active not recruiting
- NCT06705036 — Differential Study of Invasive Pituitary Adenomas in the Sellar and Cavernous Sinus Regions · recruiting
- NCT06472505 — Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage · NA · recruiting
- NCT06523582 — Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients · recruiting
- NCT05659524 — Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery · NA · recruiting
Other University Medical Center Groningen trials
Trials by the same sponsor.
- NCT06647602 — Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy · not yet recruiting
- NCT06809946 — Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy · Phase 2 · not yet recruiting
- NCT07527390 — CANagliflozin In DIALysis Patients · Phase 4 · not yet recruiting
- NCT07439237 — Implant-supported Maxillary Overdentures; a 15-years Evaluation · not yet recruiting
- NCT07275437 — Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With Reduced Ejection Fra · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06266949 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Center Groningen
- Last refreshed: 2 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06266949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing